|
Linxian nutrition intervention trial follow-up study
|
ZIA CP000112-00377
|
$254,770
|
$12,738
|
Abnet, Christian
|
DCEG (NCI)
|
|
Linxian nutrition intervention trials - etiologic studies
|
ZIA CP000112-10339
|
$94,675
|
$4,734
|
Abnet, Christian
|
DCEG (NCI)
|
|
Biologic specimen bank for early lung cancer markers in Chinese tin miners
|
ZIA CP000176-10338
|
$249,949
|
$249,949
|
Abnet, Christian
|
DCEG (NCI)
|
|
Aerobic Exercise for Smokers with Depressive Symptomatology
|
5R01CA173551-05
|
$509,755
|
$509,755
|
ABRANTES, ANA
|
BUTLER HOSPITAL (PROVIDENCE, RI)
|
|
Giant Macrophage-like Cells as a blood-based Biomarker for Lung Cancer Recurrence
|
1R43CA206840-01A1
|
$182,850
|
$182,850
|
ADAMS, DANIEL
|
CREATV MICROTECH, INC.
|
|
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (1 of 3)
|
5U54CA163069-07
|
$1,414,315
|
$70,716
|
ADUNYAH, SAMUEL
|
MEHARRY MEDICAL COLLEGE
|
|
Genotype and Imaging Phenotype Biomarkers in Lung Cancer
|
5U01CA190234-03
|
$667,641
|
$667,641
|
AERTS, HUGO
|
DANA-FARBER CANCER INST
|
|
Quantitative Radiomics System Decoding the Tumor Phenotype
|
5U24CA194354-03
|
$778,713
|
$389,357
|
AERTS, HUGO
|
DANA-FARBER CANCER INST
|
|
Use of Genetically Engineered T cells Targeting Tumor Stroma to Treat Lung Cancer
|
5R01CA172921-05
|
$357,673
|
$357,673
|
ALBELDA, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Unraveling Genetic Determinants of Lung Cancer Risk in African Americans
|
5K07CA172294-06
|
$160,123
|
$160,123
|
ALDRICH, MELINDA
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Clinical Support
|
ZIE BC 011653
|
$34,958
|
$29,715
|
Alewine, Christine
|
CCR (NCI)
|
|
Oncogenic Disruption of the Circadian Metabolic Cycle in Cancer
|
7K99CA204593-02
|
$86,521
|
$86,521
|
ALTMAN, BRIAN
|
WISTAR INSTITUTE
|
|
Integrative analysis of lung cancer etiology and risk
|
1U19CA203654-01A1
|
$2,833,706
|
$2,833,706
|
AMOS, CHRISTOPHER
|
DARTMOUTH COLLEGE
|
|
LGBT Adults and Tobacco Stigma: A Qualitative Study
|
5R01CA190238-03
|
$455,448
|
$455,448
|
ANTIN, TAMAR
|
PACIFIC INSTITUTE FOR RES AND EVALUATION
|
|
Targeting the adenosine A2A receptor immune checkpoint in lung cancer patients
|
3R01CA201124-02S1
|
$189,200
|
$189,200
|
ANTONIA, SCOTT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Targeting the adenosine A2A receptor immune checkpoint in lung cancer patients
|
5R01CA201124-02
|
$259,646
|
$259,646
|
ANTONIA, SCOTT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
The impact of e-cigarette use on adolescent uptake and persistence of conventional smoking: Who is most vulnerable?
|
5R01CA202262-02
|
$604,039
|
$604,039
|
AUDRAIN-MCGOVERN, JANET
|
UNIVERSITY OF PENNSYLVANIA
|
|
Behavioral Activation for Smoking Cessation and the Prevention of Post-Cessation Weight Gain
|
5R01CA206058-02
|
$619,045
|
$619,045
|
AUDRAIN-MCGOVERN, JANET
|
UNIVERSITY OF PENNSYLVANIA
|
|
Role of the mitochondrial citrate carrier SLC25A1(CIC)in cancer progression and therapy
|
5R01CA193698-03
|
$355,706
|
$355,706
|
AVANTAGGIATI, MARIA
|
GEORGETOWN UNIVERSITY
|
|
Modulation of the Immune System as a Strategy to Treat EGFR Mutant Lung Adenocarcinoma
|
5F31CA203488-02
|
$28,692
|
$28,692
|
AYENI, DEBORAH
|
YALE UNIVERSITY
|
|
A Psychosocial Intervention for the Caregivers of Advanced Lung Cancer Patients
|
5R01CA187143-04
|
$456,456
|
$456,456
|
BADR, HODA
|
BAYLOR COLLEGE OF MEDICINE
|
|
DNA damage signaling to immune checkpoints
|
1R01CA204173-01A1
|
$385,018
|
$385,018
|
BAKKENIST, CHRISTOPHER
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Systems genetics analysis of tumor evolution in the mouse
|
1R35CA210018-01
|
$720,018
|
$216,005
|
BALMAIN, ALLAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Genetic analysis of ras mutation specificity in skin and lung cancer
|
5R01CA184510-03
|
$362,569
|
$181,285
|
BALMAIN, ALLAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Mapping druggable co-dependency pathways in NRF2-driven lung cancers
|
1K99CA215249-01
|
$114,750
|
$114,750
|
BAR-PELED, LIRON
|
SCRIPPS RESEARCH INSTITUTE
|
|
Oncogenic Ras-induced macropinocytosis: A new paradigm for metabolic adaptation
|
5R35CA210263-02
|
$993,162
|
$496,581
|
BAR-SAGI, DAFNA
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Targeting the cytokine circuitry of KRAS-driven lung cancer
|
5R01CA190394-03
|
$394,578
|
$394,578
|
BARBIE, DAVID
|
DANA-FARBER CANCER INST
|
|
Studies of amplification in rhabdomyosarcoma
|
ZIA BC 011378
|
$218,891
|
$21,889
|
Barr, Frederic
|
CCR (NCI)
|
|
Therapeutic targeting of Fibroblast Growth Factor Receptors in Squamous Cancers
|
5R01CA196932-03
|
$387,027
|
$193,514
|
BASS, ADAM
|
DANA-FARBER CANCER INST
|
|
Predicting Pulmonary Function Change to Improve Radiation Planning and Outcome
|
5R01CA166703-05
|
$371,731
|
$371,731
|
BAYOUTH, JOHN
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Mortality among formaldehyde workers
|
ZIA CP010120-02100
|
$16,882
|
$1,688
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
Characterization of AMH as part of a novel TGF-beta signaling loop
|
5F30CA180607-04
|
$42,538
|
$42,538
|
BECK, TIM
|
DREXEL UNIVERSITY
|
|
Augmenting T cell trafficking and functionality through novel combinations of epigenetic agents and PD-1 blockade
|
1R01CA212169-01A1
|
$393,450
|
$393,450
|
BEG, AMER
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Histone Methyltransferases as a Target for Lung Cancer Prevention
|
5R01CA183296-04
|
$778,686
|
$778,686
|
BELINSKY, STEVEN
|
LOVELACE BIOMEDICAL & ENVIRONMENTAL RES
|
|
Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy
|
5R01CA196590-02
|
$850,753
|
$850,753
|
BELINSKY, STEVEN
|
LOVELACE BIOMEDICAL & ENVIRONMENTAL RES
|
|
STRESS UNDERMINES IMMUNE STIMULATION: MECHANISMS & BIOLOGICAL SIGNIFICANCE
|
5R01CA172138-05
|
$199,019
|
$49,755
|
BEN-ELIYAHU, SHAMGAR
|
TEL AVIV UNIVERSITY
|
|
Role of KDM5A in pRB-mediated differentiation
|
1R01CA211095-01
|
$365,771
|
$365,771
|
BENEVOLENSKAYA, ELIZAVETA
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Pulmonary Rehabiltation before Lung Cancer Resection
|
5R01CA163293-06
|
$268,352
|
$268,352
|
BENZO, ROBERTO
|
MAYO CLINIC ROCHESTER
|
|
A high efficiency imager for real-time lung cancer monitoring during radiotherapy
|
3R01CA188446-04S1
|
$256,320
|
$256,320
|
BERBECO, ROSS
|
DANA-FARBER CANCER INST
|
|
A high efficiency imager for real-time lung cancer monitoring during radiotherapy
|
5R01CA188446-04
|
$768,460
|
$768,460
|
BERBECO, ROSS
|
DANA-FARBER CANCER INST
|
|
Investigating the role of the small GTPase RIT1 in lung adenocarcinoma
|
4R00CA197762-03
|
$249,000
|
$249,000
|
BERGER, ALICE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Designing a Comprehensive Framework for the Evaluation of Tobacco Product Risks
|
5K07CA197221-02
|
$161,174
|
$161,174
|
BERMAN, MICAH
|
OHIO STATE UNIVERSITY
|
|
Optimizing Tobacco Dependence Treatment in the Emergency Department
|
5R01CA201873-02
|
$750,396
|
$750,396
|
BERNSTEIN, STEVEN
|
YALE UNIVERSITY
|
|
Radiobiology Outreach
|
ZIA CP010222-10441
|
$183,004
|
$18,300
|
Berrington, Amy
|
DCEG (NCI)
|
|
PathMAP NSCLC: A functional companion diagnostic test to predict optimal therapy for patients with non-small cell lung cancer.
|
4R44CA203068-02
|
$988,207
|
$988,207
|
BERTENSHAW, GREG
|
BIOMARKER STRATEGIES, LLC
|
|
Ubiquilin1 regulates EMT and metastasis of human lung adenocarcinoma
|
3R01CA193220-03S1
|
$51,321
|
$51,321
|
BEVERLY, LEVI
|
UNIVERSITY OF LOUISVILLE
|
|
Ubiquilin1 regulates EMT and metastasis of human lung adenocarcinoma
|
5R01CA193220-03
|
$352,275
|
$352,275
|
BEVERLY, LEVI
|
UNIVERSITY OF LOUISVILLE
|
|
Crosstalk of LKB1 and KEAP1 mutations in driving growth of lung adenocarcinoma
|
5R01CA206155-02
|
$403,382
|
$403,382
|
BISWAL, SHYAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Characterization of YAP as a rational companion target in lung cancer
|
1R01CA204302-01A1
|
$362,569
|
$181,285
|
BIVONA, TREVER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Optimizing biologically-based rational polytherapy in ALK+ lung cancer
|
1R01CA211052-01
|
$362,569
|
$362,569
|
BIVONA, TREVER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
Total relevant funding to Lung for this search: $270,900,315
|